Login/Sign Up
₹3500
MRP ₹350018% off
(Inclusive of all Taxes)
Get Free delivery (₹99)
Online payment accepted
Provide Delivery Location
Whats That
Therapeutic Class
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Unigrilin 20 Injection contains Eptifibatide (anti-glycoprotein IIb/IIIa receptor), which works by blocking the glycoprotein IIb/IIIa receptor's activity, thereby preventing platelet aggregation. This causes inhibition of fibrinogen binding, reducing the chance of blood clot formation.
Unigrilin 20 Injection is known to increase the risk of bleeding. However, if the patient has uncontrollable bleeding, discontinue the medicine immediately.
Unigrilin 20 Injection may cause anaemia (low haemoglobin and low red blood cell count). So, it would be best to include iron-rich food in your diet to prevent anaemia.
Alcohol
Unsafe
Alcohol intake might increase the risk of stomach or intestine bleeding. Hence, avoid alcohol consumption. Consult your doctor for more information.
Pregnancy
Unsafe
It is not recommended for use in pregnancy as it may harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Unigrilin 20 Injection. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Breast Feeding
Unsafe
It is not recommended for use in breastfeeding as it may pass into breast milk and harm your infant. Hence, if you are breastfeeding, inform your doctor before receiving Unigrilin 20 Injection. Your doctor may suggest you stop feeding while on treatment with this medicine.
Driving
Not applicable
Unigrilin 20 Injection is used in PCI procedures in a hospital setting. Driving is not recommended.
Liver
Caution
If you have liver problems, inform your doctor beforehand.
Kidney
Caution
If you have kidney impairment, inform your doctor beforehand. Unigrilin 20 Injection is not recommended for use in patients with renal toxicity.
Children
Unsafe
Unigrilin 20 Injection is not recommended for use in children below 12 years of age, as efficacy and safety have not been established.
Product Substitutes
Keep Refrigerated. Do not freeze.
About Unigrilin 20 Injection
Unigrilin 20 Injection belongs to the group of medicines called 'antiplatelet agents' used to prevent the formation of blood clots, thereby reducing the chance of Myocardial infarction. Unigrilin 20 Injection is used in the treatment of Acute coronary syndrome (ACS) in both patients who need to be managed medically and also people undergoing percutaneous coronary intervention (PCI) procedures. ACS is defined as a group of serious cardiac conditions wherein the blood flow to the heart decreases due to plaque formation. Unigrilin 20 Injection is also used in the treatment of patients undergoing urgent PCI procedures and also in patients undergoing intracoronary stenting.
Unigrilin 20 Injection contains Eptifibatide, which belongs to the monoclonal anti-glycoprotein IIb/IIIa receptor antibodies class. It works by blocking the glycoprotein IIb/IIIa receptor's activity, thereby preventing platelet aggregation. This causes inhibition of fibrinogen binding, reducing the chance of blood clot formation. Unigrilin 20 Injection reduces the risk of cardiovascular events like myocardial infarction (heart attack).
Unigrilin 20 Injection may cause certain side effects, such as bleeding, nausea, headache, abdominal pain, hypotension, vomiting, dizziness, decreased platelet count, and pain at the site of injection. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor. A trained healthcare professional will administer Unigrilin 20 Injection. So, do not self-administer. Your doctor will decide the dose of the medicine based on your health condition.
Unigrilin 20 Injection should be avoided if you are allergic to it. It is contraindicated in patients who have active internal bleeding, history of bleeding diathesis within 30 days, thrombocytopenia, severe uncontrolled hypertension, had recent major surgery or trauma, renal failure, using another glycoprotein IIb/IIIa inhibitor, a history of cerebrovascular accident within the last two years, or recent gastrointestinal or genitourinary bleeding, intracranial neoplasm, aneurysm, as it can cause serious adverse effects. Unigrilin 20 Injection is known to cause bleeding problems. If you observe severe bleeding that cannot be controlled, it is advised to stop administering Unigrilin 20 Injection immediately. Hence, close monitoring is needed for any bleeding conditions. Talk to your doctor before receiving Unigrilin 20 Injection if you had a recent severe injury or surgery due to the risk of severe bleeding problems. If you are pregnant, planning to become pregnant, or breastfeeding, inform your doctor before taking Unigrilin 20 Injection. Unigrilin 20 Injection is not recommended for children below 12 years of age as efficacy and safety have not been established.
Uses of Unigrilin 20 Injection
Medicinal Benefits
Unigrilin 20 Injection contains Eptifibatide, which belongs to the monoclonal anti-glycoprotein IIb/IIIa receptor antibodies class. It works by blocking the glycoprotein IIb/IIIa receptor's activity, thereby preventing platelet aggregation. This causes inhibition of fibrinogen binding, reducing the chance of blood clot formation. Unigrilin 20 Injection results in reducing the risk of cardiovascular events like myocardial infarction (heart attack) and other cardiac events.
Directions for Use
Side Effects of Unigrilin 20 Injection
Drug Warnings
Do not receive Unigrilin 20 Injection if you are allergic to it. It is contraindicated in patients who have active internal bleeding, history of bleeding diathesis within 30 days, thrombocytopenia, severe uncontrolled hypertension, had recent major surgery or trauma, renal failure, using another glycoprotein IIb/IIIa inhibitor, a history of cerebrovascular accident within the last two years, or recent gastrointestinal or genitourinary bleeding, intracranial neoplasm, aneurysm, as it can cause serious adverse effects. Unigrilin 20 Injection is known to cause bleeding problems. However, if you observe severe bleeding that cannot be controlled, it is advised to stop administering Unigrilin 20 Injection immediately. Hence, close monitoring of patients is needed for any bleeding conditions. Talk to your doctor before receiving Unigrilin 20 Injection if you had a recent severe injury or surgery due to the risk of severe bleeding problems. Before taking Unigrilin 20 Injection inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding due to serious foetal harm. Unigrilin 20 Injection is not recommended for children below 12 years of age as efficacy and safety have not been established. Talk to your doctor before receiving Unigrilin 20 Injection if you have/had a recent severe injury or surgery due to the risk of severe bleeding problems.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
Login/Sign Up
Drug-Drug Interactions Checker List
Habit Forming
Special Advise
Diet & Lifestyle Advise
Have a query?
Buy best Cardiology products by
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Lupin Ltd
Intas Pharmaceuticals Ltd
Cipla Ltd
Micro Labs Ltd
Macleods Pharmaceuticals Ltd
Abbott India Ltd
Ajanta Pharma Ltd
Ipca Laboratories Ltd
Eris Life Sciences Ltd
Mankind Pharma Pvt Ltd
Lloyd Healthcare Pvt Ltd
Dr Reddy's Laboratories Ltd
Glenmark Pharmaceuticals Ltd
Emcure Pharmaceuticals Ltd
Alembic Pharmaceuticals Ltd
Alkem Laboratories Ltd
East West Pharma India Pvt Ltd
USV Pvt Ltd
Zydus Healthcare Ltd
Aristo Pharmaceuticals Pvt Ltd
Elbrit Life Sciences Pvt Ltd
J B Chemicals & Pharmaceuticals Ltd
Zydus Cadila
Akumentis Healthcare Ltd
Alteus Biogenics Pvt Ltd
Hbc Life Sciences Pvt Ltd
Fusion Health Care Pvt Ltd
Troikaa Pharmaceuticals Ltd
La Renon Healthcare Pvt Ltd
Corona Remedies Pvt Ltd
Jubilant Lifesciences Ltd
Medley Pharmaceuticals Ltd
Knoll Healthcare Pvt Ltd
Msn Laboratories Pvt Ltd
Zuventus Healthcare Ltd
Cadila Pharmaceuticals Ltd
Blue Cross Laboratories Pvt Ltd
Lividus Pharmaceuticals Pvt Ltd
Morepen Laboratories Ltd
Ranmarc Labs
Shrrishti Health Care Products Pvt Ltd
Sanofi India Ltd
Steris Healthcare
Elder Pharmaceuticals Ltd
Primus Remedies Pvt Ltd
Unison Pharmaceuticals Pvt Ltd
Eswar Therapeutics Pvt Ltd
Knoll Pharmaceuticals Ltd
Tas Med India Pvt Ltd
Systopic Laboratories Pvt Ltd
Indiabulls Pharmaceuticals Pvt Ltd
Leeford Healthcare Ltd
Sinsan Pharmaceuticals Pvt Ltd
Biochem Pharmaceutical Industries Ltd
Cadila Healthcare Ltd
Azkka Pharmaceuticals Pvt Ltd
Nirvana India Pvt Ltd
Orsim Pharma
Prevego Healthcare & Research Pvt Ltd
Econ Healthcare
Elinor Pharmaceuticals (P) Ltd
FDC Ltd
Sunij Pharma Pvt Ltd
Nicholas Piramal India Ltd
Astra Zeneca Pharma India Ltd
Pfizer Ltd
Lia Life Sciences Pvt Ltd
Shine Pharmaceuticals Ltd
Elicad Pharmaceuticals Pvt Ltd
Indoco Remedies Ltd
Proqol Health Care Pvt Ltd
Vasu Organics Pvt Ltd
Biocon Ltd
Opsis Care Lifesciences Pvt Ltd
Johnlee Pharmaceuticals Pvt Ltd
Merck Ltd
Wockhardt Ltd
Auspharma Pvt Ltd
Ergos Life Sciences Pvt Ltd
Lakshya Life Sciences Pvt Ltd
Ordain Health Care Global Pvt Ltd
Pficus De Med Pvt Ltd
ALICAN PHARMACEUTICAL PVT LTD
RPG Life Sciences Ltd
Glynis Pharmaceuticals Pvt Ltd
Orris Pharmaceuticals
Samarth Life Sciences Pvt Ltd
Aprica Pharmaceuticals Pvt Ltd
Aretaeus Pharmaceuticals Pvt Ltd
Koye Pharmaceuticals Pvt Ltd
Neocardiab Care
Retra Life Science Pvt Ltd
Alniche Life Sciences Pvt Ltd
Alvio Pharmaceuticals Pvt Ltd
Arkas Pharma Pvt Ltd
Atos Lifesciences Pvt Ltd
Divine Savior Pvt Ltd
Metalis Lifesciences Pvt Ltd